CXCL8 and psoriasis: Although blockade of IL-8 and neutrophil apheresis have shown some effects in pustular variants of psoriasis 27,28, it is unlikely that targeting of neutrophils or single neutrophil-chemotactic factors alone will be a successful therapeutic approach in plaque-type psoriasis.